The weekly litigation news digest is live. Subscribe now

IP Verse

Murray & Poole Enterprises competitive analysis

Loading summary...

Latest patents of Murray & Poole Enterprises opposed by its competitors

Explore Murray & Poole Enterprises's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Nov 20, 2025
Patent NumberPublication DateTitleTotal Oppositions
EP2914255
Jul 21, 2021Treatment Or Prevention Of Cardiovascular Events Via The Administration Of A Colchicine Derivative2

Latest PTAB cases involving Murray & Poole Enterprises

Discover the latest PTAB cases involving Murray & Poole Enterprises, highlighting their recent legal challenges and patent disputes.

Last updated on: Nov 20, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Murray & Poole Enterprises

IPR2023-01064Jun 16, 2023MURRAY & POOLE ENTERPRISESINSTITUT DE CARDIOLOGIE DE MONTRALFinal Written Decision - Appealed

Peer Comparison New

IP litigation analysis comparing Murray & Poole Enterprises with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 20, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
MURRAY & POOLE ENTERPRISES - 21 -
INSTITUT DE CARDIOLOGIE DE MONTRAL - - - 1
PHARMASCIENCE1 - - -
TEVA PHARMACEUTICALS20916 - 12